Literature DB >> 11393722

High-performance liquid chromatographic assay of zonisamide in human plasma using a non-porous silica column.

M Nakamura1, K Hirade, T Sugiyama, Y Katagiri.   

Abstract

A new method for measuring zonisamide (ZNS) in plasma by high-performance liquid chromatography was developed by using a 2-microm reversed-phase non-porous silica column. ZNS in plasma was first purified with a column extraction technique and injected onto the non-porous silica column. Calibration curve was linear over the concentration range of 1-80 microg/ml in plasma. The recoveries of ZNS added to plasma were more than 95.4% with the coefficient of variation less than 9.0%. We developed a rapid routine method using the non-porous silica column that was accurate and improved solvent consumption in the measurement of ZNS.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11393722     DOI: 10.1016/s0378-4347(01)00062-7

Source DB:  PubMed          Journal:  J Chromatogr B Biomed Sci Appl        ISSN: 1387-2273


  8 in total

1.  Simultaneous determination of lamotrigine, zonisamide, and carbamazepine in human plasma by high-performance liquid chromatography.

Authors:  Elizabeth Greiner-Sosanko; Darla R Lower; Mohamed A Virji; Matthew D Krasowski
Journal:  Biomed Chromatogr       Date:  2007-03       Impact factor: 1.902

2.  Drug monitoring: simultaneous analysis of lamotrigine, oxcarbazepine, 10-hydroxycarbazepine, and zonisamide by HPLC-UV and a rapid GC method using a nitrogen-phosphorus detector for levetiracetam.

Authors:  Elizabeth Greiner-Sosanko; Spiros Giannoutsos; Darla R Lower; Mohamed A Virji; Matthew D Krasowski
Journal:  J Chromatogr Sci       Date:  2007-10       Impact factor: 1.618

3.  HPLC method for simultaneous determination of impurities and degradation products in zonisamide.

Authors:  E K S Vijayakumar; D M Dhore; M Kumar
Journal:  Indian J Pharm Sci       Date:  2009-09       Impact factor: 0.975

4.  Therapeutic Drug Monitoring of the Newer Anti-Epilepsy Medications.

Authors:  Matthew D Krasowski
Journal:  Pharmaceuticals (Basel)       Date:  2010-06-11

5.  Rapid and sensitive high performance liquid chromatographic determination of zonisamide in human serum application to a pharmacokinetic study.

Authors:  M B Majnooni; B Mohammadi; R Jalili; G H Bahrami
Journal:  Indian J Pharm Sci       Date:  2012-07       Impact factor: 0.975

6.  Determination and Validation of Zonisamide and its Four Related Substances by HPLC and UV-Spectrophotometry.

Authors:  Maryam Hosseini; E Alipour; Arezou Farokhsir
Journal:  Indian J Pharm Sci       Date:  2010-05       Impact factor: 0.975

7.  Comparison of performance characteristics between high-performance liquid chromatography and latex agglutination turbidimetric immunoassay for therapeutic drug monitoring of zonisamide.

Authors:  Daiki Eto; Ryota Tanaka; Yosuke Suzuki; Yuhki Sato; Hiroki Itoh
Journal:  J Clin Lab Anal       Date:  2019-06-20       Impact factor: 2.352

8.  Quantification of Zonisamide in Dried Blood Spots and Dried Plasma Spots by UPLC-MS/MS: Application to Clinical Practice.

Authors:  Milena Rmandić; Ana Stajić; Jasna Jančić; Janko Samardžić; Nebojša Jović; Anđelija Malenović
Journal:  Molecules       Date:  2022-07-31       Impact factor: 4.927

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.